Skip to main content
OpenTrials
Completed

NCT Number: NCT06697340

Braden Pressure Ulcer Scale for Prediction of the Intensive Care Length of Stay

The aim of this study is to predict the length of intensive care unit stay of patients treated in a tertiary general intensive care unit with the help of the Braden risk assesment scale, which is used to predict the risk of pressure ulcers. The main question it aims to answer is:

* Does high Braden scales predict the long lenght of stay? Braden scales of patients admitted to the intensive care unit were recorded every day.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Intensive Care Unit ICU Length of ICU Stay Pressure Ulcer Risk Scale Reliability Validity

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ankara Bilkent City Hospital

Ankara, Turkey (Türkiye)

About this study

Intensive care units are specialized units where patients with multiple comorbidities are treated. The length of stay in intensive care varies according to the characteristics of the patient, the disease and the center. Prolonged intensive care stay causes an increase in mortality . It has been reported that the severity of the disease as well as the comorbidities of the patients contribute to prolonged stay . One third of patients with stay longer than seven days were evaluated as more fragile than before hospital admission. Prolonged intensive care length of stay leads to an increase in morbidity and mortality, bed demand and costs.

The Braden pressure ulcer scale was developed by Braden et al. in 1987 . Scoring is done under six different headings evaluating sensory perception, humidity, activity, mobility, nutrition and friction/cutting. It has been reported as an effective tool for evaluating pressure ulcer development in intensive care patients. In this scoring system, there are different assessment steps such as mobility, nutrition, sensory perception, etc., which allows the assessment of the functional capacity of the patients at the time of admission. In a study of elderly dementia patients, the Braden scale was found to be effective in predicting 90-day mortality. In a retrospective evaluation of patients with heart failure, the Braden scale was reported to predict 30-day mortality.

The aim of our study is to predict the length of intensive care stay by analyzing the Braden scales calculated on the day of hospitalization.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients older than 18 years
  • Patients treated in intensive care
  • Patients treated with diagnoses other than Covid-19
  • Patients without missing data in the hospital electronic data system
  • Patients hospitalized for more than 24 hours

Exclusion criteria

  • Patients younger than 18 years
  • Patients treated for Covid-19 disease
  • Patients with missing data in the hospital electronic data system
  • Patients hospitalized for less than 24 hours

Treatment and study plan

Primary outcomes

  1. Intensive care length of stay

    Time frame: Time period between patient admission to intensive care unit and patient discharge, patient transfer to ward or patient death, whichever came first. Estimated time up to 52 weeks

    Patient intensive care length of stay

Secondary outcomes

  1. Mortality

    Time frame: Time interval between patient intensive care unit admission to patient mortality. Estimated time is up to 52 weeks

    All-cause mortality rate in the intensive care unit.

Sponsors and collaborators

Lead sponsor

Ankara City Hospital Bilkent

Other

Registry information

Official study title

The Effect of the Braden Pressure Ulcer Scale on the Prediction of Intensive Care Unit Length of Stay

Acronym: BRILS

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Nov 20, 2024
Registry last updated
Jul 28, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.